Use of anthrax vaccine in the United States.
These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
D000881:Anthrax / Q000517:prevention & control*; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D019072:Antibiotic Prophylaxis; D000075202:Contraindications; D006801:Humans; D014481:United States; D014611:Vaccination / Q000592:standards*
D022122:Anthrax Vaccines